Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease

NCT ID: NCT01544465

Last Updated: 2014-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the ability of a structured physical activity program to improve sleep quality and daytime sleepiness in patients with Parkinson's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Parkinson's disease (PD) is a chronic, progressive, neurodegenerative disease that affects 1% of elderly people. Sleep disturbances affect up to 88% of patients with PD and commonly include sleep fragmentation and excessive daytime sleepiness (EDS); these symptoms can significantly impair quality of life. The cause of sleep fragmentation and EDS is likely multifactorial, including medications, neurodegeneration, primary sleep disorders such as sleep apnea, and decreased physical activity. Pharmacotherapy in this population is limited due to side effects and drug-drug interactions.

The goal of this project is to develop non-pharmacologic therapies for impaired sleep quality and EDS in PD. Sleep disturbances and EDS are common among patients with PD and negatively affect their quality of life. There is data to support a role for physical activity in sleep in older adults with and without insomnia. Additionally, increased physical activity in patients with PD has been associated with improvement in PD motor symptoms and quality of life. Therefore, the investigators propose to examine the ability of structured physical activity to improve sleep quality and daytime sleepiness in patients with PD.

The overall objective of the proposed project is to develop behavioral approaches to improve sleep quality and daytime function in PD. The investigators propose to examine the effect of a structured physical activity program and sleep hygiene education on nighttime sleep quality and EDS in patients with idiopathic PD. There will be two groups: 1) a structured physical activity program with sleep hygiene education (SPA group), and 2) a control group receiving only sleep hygiene education (SH group) who will be offered the delayed physical activity program.

The investigators hypothesize that the structured physical activity program will improve subjective and objective sleep quality and daytime sleepiness compared to sleep hygiene education alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease Poor Quality Sleep Hypersomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Structured physical activity

Rehabilitation evaluation followed by physical therapy for approximately 8 weeks

Group Type EXPERIMENTAL

Structured Physical Activity

Intervention Type BEHAVIORAL

Rehabilitation evaluation and 8 weeks of physical therapy

Sleep hygiene education

Sleep hygiene education consists of educational materials on insomnia published by the American Academy of Sleep Medicine.

Group Type ACTIVE_COMPARATOR

Structured Physical Activity

Intervention Type BEHAVIORAL

Rehabilitation evaluation and 8 weeks of physical therapy

Sleep hygiene education

Intervention Type BEHAVIORAL

Educational materials on insomnia published by the American Academy of Sleep medicine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured Physical Activity

Rehabilitation evaluation and 8 weeks of physical therapy

Intervention Type BEHAVIORAL

Sleep hygiene education

Educational materials on insomnia published by the American Academy of Sleep medicine

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Review of sleep hygiene checklist every 2 weeks via telephone for 8 weeks.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Established clinical diagnosis of Hoehn and Yahr stage I to III idiopathic Parkinson's disease,
* Male and female.
* Age of onset of PD \>= 50 years;
* Impaired sleep quality determined by Parkinson's disease sleep scale (PDSS-2) total score ≥ 12;
* EDS as determined by Epworth Sleepiness Scale (ESS) \> 10;
* Sedentary (\< 30 minutes/day or \< 2 times/week of exercise) based on physical activity history;
* Stable on medications for PD for at least 2 months;
* After clinical evaluation, was provided with a referral by their Movement Disorders Neurologist for an evaluation at the Movement Disorders Rehabilitation Evaluation Clinic at the Rehabilitation Institute of Chicago.

Exclusion Criteria

* Cognitive impairment as determined by Montreal Cognitive Assessment (MoCA) total score \< 25;
* High likelihood of sleep disordered breathing as determined by the Berlin Questionnaire (BQ);
* Restless legs syndrome (RLS) based on the International RLS Study Group diagnostic criteria;
* Current use of any sedative/hypnotics or stimulants, tricyclic antidepressants, and trazodone;
* Use of selective serotonin reuptake inhibitors (SSRIs) and bupropion will be allowed only if the patient has been on a stable dose for at least three months;
* Unstable medical or psychiatric condition;
* History of falls in the last 2 months;
* Participants with parasomnias such as Rapid Eye Movement Behavior Disorder will not be excluded as up to 50% of patients with PD have parasomnias and exclusion of these patients would result in difficulty with recruitment and the results would be less generalizable;
* Current depression based on BDI-II total score \> 19;
* Current occupation involves shift work;
* At visit #2, Apnea-hypopnea index \>15 on baseline PSG;
* At visit #2, Periodic limb movements in sleep index \>15 on baseline PSG;
* At physiatry evaluation at RIC, inpatient rehabilitation is recommended.
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shirley Ryan AbilityLab

OTHER

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roneil Malkani

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Phyllis C Zee, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Northwestern University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology. 2007 Jan 30;68(5):326-37. doi: 10.1212/01.wnl.0000252807.38124.a3.

Reference Type BACKGROUND
PMID: 17261678 (View on PubMed)

Menza M, Dobkin RD, Marin H, Bienfait K. Sleep disturbances in Parkinson's disease. Mov Disord. 2010;25 Suppl 1(Suppl 1):S117-22. doi: 10.1002/mds.22788.

Reference Type BACKGROUND
PMID: 20187236 (View on PubMed)

Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology. 2001 Oct 23;57(8):1392-6. doi: 10.1212/wnl.57.8.1392.

Reference Type BACKGROUND
PMID: 11673578 (View on PubMed)

King AC, Oman RF, Brassington GS, Bliwise DL, Haskell WL. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA. 1997 Jan 1;277(1):32-7.

Reference Type BACKGROUND
PMID: 8980207 (View on PubMed)

Li F, Fisher KJ, Harmer P, Irbe D, Tearse RG, Weimer C. Tai chi and self-rated quality of sleep and daytime sleepiness in older adults: a randomized controlled trial. J Am Geriatr Soc. 2004 Jun;52(6):892-900. doi: 10.1111/j.1532-5415.2004.52255.x.

Reference Type BACKGROUND
PMID: 15161452 (View on PubMed)

Reid KJ, Baron KG, Lu B, Naylor E, Wolfe L, Zee PC. Aerobic exercise improves self-reported sleep and quality of life in older adults with insomnia. Sleep Med. 2010 Oct;11(9):934-40. doi: 10.1016/j.sleep.2010.04.014. Epub 2010 Sep 1.

Reference Type BACKGROUND
PMID: 20813580 (View on PubMed)

Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. J Rehabil Res Dev. 2000 Sep-Oct;37(5):529-34.

Reference Type BACKGROUND
PMID: 11322151 (View on PubMed)

Rodrigues de Paula F, Teixeira-Salmela LF, Coelho de Morais Faria CD, Rocha de Brito P, Cardoso F. Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson's disease. Mov Disord. 2006 Aug;21(8):1073-7. doi: 10.1002/mds.20763.

Reference Type BACKGROUND
PMID: 16637049 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

67-PA-11

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

STU00045490

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Proprioception and Meditation
NCT03079817 COMPLETED NA